December 27, 20211. The concept of intravenous contrast mediaThere are many types of contrast medium in the clinic, and different types of contrast medium will produce different feelings after they are injected into p...view
July 11, 2024Recently, the Beijing Municipal Drug Administration and the Beijing Municipal Health Commission released a "Notification on Units and Individuals with Outstanding Performance in Drug, Medical Dev...view
March 7, 2023Recently, Zhejiang Haichang Pharmaceutical Co., Ltd., a subsidiary of Beijing Beilu Pharmaceutical Co., Ltd., received a registration certificate for its active pharmaceutical ingredient product from ...view
February 24, 2023Recently, the "Wealth and Responsibility - Values of Enterprises" 2022 China Top 500 Charity List Conference was held in Chongqing. Since its inclusion in 2021, Beilu Pharmaceutical has been...view
May 29, 2023Beijing Beilu Pharmaceutical Co., Ltd invites youto participate in the 2023 World Life Science Conference and Beijing International Life and Health Industry Cross-border ExpoBooth Number: 1B210Exhibit...view
April 8, 2022Beijing Beilu Pharmaceutical Co., Ltd. (300016) announced today that Gadobutrol injection has obtained the "Drug Registration Certificate" issued by the NMPA(National Medial Production Administr...view